TECH Share Price

Open 105.89 Change Price %
High 107.52 1 Day 0.86 0.81
Low 105.89 1 Week 4.86 4.78
Close 106.62 1 Month 6.61 6.61
Volume 154734 1 Year 14.06 15.19
52 Week High 117.42
52 Week Low 91.45
TECH Important Levels
Resistance 2 108.13
Resistance 1 107.51
Pivot 106.68
Support 1 105.73
Support 2 105.11
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
SIRI 5.02 -1.76%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
INTC 37.43 1.35%
INTC 37.43 1.35%
More..
NASDAQ USA Top Gainers Stocks
SPIR 0.02 100.00%
LOCM 0.09 50.00%
IFON 0.63 34.04%
WRES 0.09 28.57%
SMSI 1.13 28.41%
EXAS 30.14 26.64%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
OPHC 2.80 21.21%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
PGRX 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SNCR 13.29 -46.02%
DVOX 0.05 -44.44%
More..

Techne Corporation (NASDAQ: TECH)

TECH Technical Analysis 4
As on 27th Apr 2017 TECH Share Price closed @ 106.62 and we RECOMMEND Buy for LONG-TERM with Stoploss of 106.29 & Strong Buy for SHORT-TERM with Stoploss of 103.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
TECH Target for April
1st Target up-side 107.12
2nd Target up-side 110.96
3rd Target up-side 114.79
1st Target down-side 96.18
2nd Target down-side 92.34
3rd Target down-side 88.51
TECH Other Details
Segment EQ
Market Capital 2603798528.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.techne-corp.com
TECH Address
TECH
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States
Phone: 612-379-8854
Fax: 612-379-6580
TECH Latest News
Favorable Media Coverage Very Unlikely to Impact BIO-TECHNE Corp (TECH) Share ...   BBNS   - 28th Apr 17
Equity Focus: Looking at Shares of Bio-Techne Corp (TECH)   Benton Bulletin   - 27th Apr 17
$143.52 Million in Sales Expected for BIO-TECHNE Corp (TECH) This Quarter   The Cerbat Gem   - 27th Apr 17
BIO-TECHNE Corp (TECH) Given Daily Media Impact Rating of 0.56   The Cerbat Gem   - 26th Apr 17
BIO-TECHNE Corp (TECH) Cut to Neutral at Janney Montgomery Scott   Transcript Daily   - 25th Apr 17
Bio-Techne Corporation Completed its Acquisition of Advanced Cell Diagnostics   PR Newswire (press release)   - 02nd Aug 16
Staying Cautious On Bio-Techne For Now   Seeking Alpha   - 18th Jul 16
Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene ...   PR Newswire (press release)   - 04th May 16
Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.   PR Newswire (press release)   - 21st Mar 16
103.1474   MarketWatch   - 03rd Sep 09
Interactive Technical Analysis Chart Techne Corporation ( TECH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Techne Corporation
TECH Business Profile
TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide. In July 2013, the Company announced that it has completed the acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).